Clinical Trials Directory

Trials / Completed

CompletedNCT06294626

Examination of Neuromotor Development of Cases Diagnosed with Scaphocephaly

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Acıbadem Atunizade Hospital · Academic / Other
Sex
All
Age
2 Months – 17 Months
Healthy volunteers
Not accepted

Summary

It's an observational study. Purpose of the study: To evaluate the neuromotor development of scaphocephaly cases. 21 infants diagnosed with scaphocephaly aged 2-17 months were included. * Is there any delay in the neuromotor development of scaphocephaly cases? * If delay is observed, in which area is it most common? Denver-II Developmental Screening Test and Alberta Motor Infant Scale were applied to the participants.

Detailed description

Scaphocephaly (sagittal synostosis) is the most common single-suture craniosynostosis. It occurs as a result of premature ossification of the fibrous connective tissue extending between two parietal bones (sagittal suture). Phenotypically, a long and narrow head shape occurs. It occurs in 2-3 per 10,000 live births and is more common in men. Premature ossification of the sagittal suture can lead to cranial deformity, potentially cranial growth restriction, and resulting increased intracranial pressure. In these cases, increased intracranial pressure and compression of the sagittal sinus cause increased venous pressure, which may cause developmental delays. These delays most commonly include cognitive impairments, language disorders, motor delays, learning disabilities, executive dysfunction, and behavioral problems. When looking at the literature, it was seen that the studies were mostly on neurocognitive development in cases with craniosynostosis. There are relatively fewer studies focusing on the neuromotor development of these cases. This study aims to evaluate the neuromotor development of scaphocephaly cases.

Conditions

Interventions

TypeNameDescription
OTHERGroup 121 cases with scaphocephaly diagnoses were included. Neuromotor development was evaluated with the Denver-II Developmental Screening Test and Alberta Infant Motor Scale.

Timeline

Start date
2019-01-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2024-03-05
Last updated
2024-09-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06294626. Inclusion in this directory is not an endorsement.